Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Current Deferred Tax Assets (2014 - 2015)

Updated

Aytu Biopharma's Current Deferred Tax Assets came in at $94,211 for fiscal Q1 2016 (quarter ended Sep 30, 2015), up 127.4% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

At the end of FY2015 (ended Jun 30, 2015), Aytu Biopharma's Current Deferred Tax Assets was $41,427, up 119.2% from FY2014.

  • Going back by fiscal year, Current Deferred Tax Assets was $18,897 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 94,211.00
Jun 30, 2015 41,427.00
Jun 30, 2014 18,897.00
API Access

Aytu Biopharma Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=AYTU&period=max&api_key=YOUR_API_KEY